Colorectal cancer risk is associated with biochemical markers for B-vitamin deficiency (plasma folate and homocysteine), insulin resistance (plasma insulin, free fatty acids and triacylglycerol) and colonic inflammation (faecal calprotectin) as shown in Table 1, column 1. This evidence concerns the gene INS and colorectal cancer.